The author of the Life Sciences Industrial Strategy
report to Government, Professor Sir , will face questioning by
the House of Lords Science and Technology Committee on Tuesday 5
December.
Sir John’s report seeks to provide the Government
with recommendations which will ensure the long term success of
the life sciences sector. It states that if these recommendations
are implemented, the strategy will “emerge as a dynamic set of
actions that will ensure the most desirable outcomes for the
economy, industry and the NHS”.
The Committee will ask Sir John how the strategy
should be implemented and whether the goal of making the UK
attractive to global life sciences investors can be
achieved.
The evidence session will begin at 10:10am in
Committee Room 4A of the House of Lords.
Further questions the Committee are likely to
ask include:
-
Industry has expressed frustration at the slow
uptake of new medicines by the NHS, the difficulty of
collaborating with the NHS and the NHS's poor record of
adopting innovation. What are the solutions?
-
When is it expected that the life sciences sector
deal will be published and what would you like it to
contain?
-
What effect will Brexit have on the implementation
of the strategy?
-
We have heard evidence that the goal of four
companies in life sciences with market capitalisation of £20bn
in the next 10 years is extremely ambitious considering the
UK's track record and the problems facing the sector. How can
this goal can be met?
